This study demonstrates the potential of S. miltiorrhiza for COVID-19 treatment, consisting first of the blockade of the binding by the S1-subunit to the ACE2 receptor and of the mitigation of the inflammatory response from leukocytes by interfering with NFκB signaling activation. This evidence concerns the gene NFKB1 and COVID-19.